One-puncture one-needle TRUS-guided prostate biopsy for prevention of postoperative infections.
- Author:
Xiao-Fu QIU
1
;
Guo-Sheng YANG
1
;
Bo-Te CHEN
1
;
Li MA
2
Author Information
1. Department of Urology, The Second People's Hospital of Guangdong Province, Guangzhou, Guangdong 510317, China.
2. Department of Ultrasound, The Second People's Hospital of Guangdong Province, Guangzhou, Guangdong 510317, China.
- Publication Type:Journal Article
- Keywords:
one-puncture one-needle;
transrectal ultrasound;
prostate biopsy
- MeSH:
Bacteremia;
etiology;
Biopsy, Fine-Needle;
adverse effects;
instrumentation;
methods;
Case-Control Studies;
Feasibility Studies;
Humans;
Male;
Prostate;
pathology;
Prostate-Specific Antigen;
blood;
Prostatic Neoplasms;
blood;
pathology;
Retrospective Studies;
Sterilization;
methods;
Ultrasonography, Interventional;
Urinary Tract Infections;
prevention & control
- From:
National Journal of Andrology
2017;23(7):630-634
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore the feasibility and effectiveness of "one-puncture one-needle" transrectal ultrasound (TRUS)-guided prostate biopsy in the prevention of postoperative infections.
METHODS:We retrospectively analyzed the clinical data about "one-puncture one-needle" (the observation group) and "one-person one-needle" (the control group) TRUS-guided prostate biopsy performed in the Second People's Hospital of Guangdong Province from January 2005 to December 2015, and compared the incidence rates of puncture-related infection between the two strategies. By "one-puncture one-needle", one needle was used for one biopsy puncture, while by "one-person one-needle", one needle was used for all biopsy punctures in one patient and the needle was sterilized with iodophor after each puncture.
RESULTS:Totally, 120 patients received 6+1-core or 12+1-core "one-person one-needle" and 466 underwent 12+1-core "one-puncture one-needle" TRUS-guided prostate biopsy. There were no statistically significant differences between the two groups of patients in age, the prostate volume, the serum PSA level, or the detection rate of prostate cancer (P >0.05). Compared with the control group, the observation group showed remarkably lower incidence rates of puncture-related urinary tract infection (7.5% vs 0.9%, P <0.05), fever (5.0% vs 1.1%, P <0.05), bacteriuria (2.5% vs 0.2%, P <0.05), and total infections (16.7% vs 2.6%, P<0.05) postoperatively. Two cases of bacteremia or sepsis were found in each of the groups, with no significant difference between the two.
CONCLUSIONS:"One-puncture one-needle" TRUS-guided prostate biopsy can effectively prevent puncture-related infections.
